The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Incidence and prognostic value of actionable mutations in early-stage resectable cholangiocarcinoma.
 
Kailey Morgan Oppat
No Relationships to Disclose
 
Emilie AK Warren
No Relationships to Disclose
 
Frances J. Bennett
No Relationships to Disclose
 
Amanda Nottke
Employment - InVitae; InVitae
Stock and Other Ownership Interests - InVitae
 
Hana E. Littleford
Employment - Invitae
Stock and Other Ownership Interests - Invitae
 
Kim M. Phelps
No Relationships to Disclose
 
Karen R. Pennington
Employment - InVitae
Stock and Other Ownership Interests - InVitae
 
Ashokkumar A. Patel
No Relationships to Disclose
 
Melinda Bachini
Honoraria - AstraZeneca; Boehringer Ingelheim; Kinnate Biopharma; Relay Therapeutics; Taiho Pharmaceutical
Consulting or Advisory Role - AstraZeneca; Taiho Pharmaceutical
Travel, Accommodations, Expenses - AstraZeneca; Relay Therapeutics; Taiho Pharmaceutical
Other Relationship - Taiho Pharmaceutical
(OPTIONAL) Uncompensated Relationships - ECOG-ACRIN; NCCN; NCI
 
Stacie Lindsey
Leadership - Cholangiocarcinoma Foundation
 
Shishir K. Maithel
Consulting or Advisory Role - AstraZeneca
Research Funding - Celgene